Growth and survival of Epstein-Barr virus (EBV)-immortalized B lymphocytes cultured at low cell densities require autocrine soluble factors. In this study, we have purified a low molecular weight autocrine soluble factor that promotes growth of EBV-immortalized B cells in serum-free conditions and identified it as lactic acid (LA). Synthetic LA stimulated growth in EBV-immortalized B cells at 1-10 mM, a concentration of LA measured in the culture supernatant of EBV-immortalized cell lines. LA alone was found to account for >70% of the autocrine growth factor activity in serum-free supernatants of EBV-immortalized B cells. Aminooxyacetate, a glutamate-oxaloacetate trnsamnase inhibitor, specifically inhibited B-cell growth induced by LA, suggesting that this process requires mitochondrial-cytosol transfers. Thus, LA is an autocrine stimulatory molecule that in serum-free conditions is essential for the continuous proliferation of EBVImmortalized B cells. This represents an unexpected function for LA.
ABSTRACT
Growth and survival of Epstein-Barr virus (EBV)-immortalized B lymphocytes cultured at low cell densities require autocrine soluble factors. In this study, we have purified a low molecular weight autocrine soluble factor that promotes growth of EBV-immortalized B cells in serum-free conditions and identified it as lactic acid (LA). Synthetic LA stimulated growth in EBV-immortalized B cells at 1-10 mM, a concentration of LA measured in the culture supernatant of EBV-immortalized cell lines. LA alone was found to account for >70% of the autocrine growth factor activity in serum-free supernatants of EBV-immortalized B cells. Aminooxyacetate, a glutamate-oxaloacetate trnsamnase inhibitor, specifically inhibited B-cell growth induced by LA, suggesting that this process requires mitochondrial-cytosol transfers. Thus, LA is an autocrine stimulatory molecule that in serum-free conditions is essential for the continuous proliferation of EBVImmortalized B cells. This represents an unexpected function for LA.
Epstein-Barr virus (EBV) can infect human B lymphocytes and induce their immortalization into long-term cell lines (1).
The mechanisms responsible for initiation and maintenance of B-cell immortalization by EBV are largely unknown, except that a number of viral genes are believed to play a role in these processes (for a review, see ref. 2) .
Over the last several years it has become clear that a critically important event in the process of B-cell immortalization by EBV is the establishment of an autocrine loop, where the virally infected cells secrete growth factors in the culture supernatant and then utilize them to grow (3) (4) (5) . The existence of such autocrine loop is demonstrated by the observation that, if cultured at critically low cell densities, EBV-immortalized cells stop growing and soon die. This outcome can be prevented by supplementation of the culture medium with supernatants of EBV-immortalized cells cultured at optimal cell densities (3) (4) (5) .
At present, the molecular nature of the factors responsible for autocrine growth stimulation of EBV-immortalized cells is incompletely defined. Interleukin 6 (IL-6) accounts for a portion (<30M) of the autocrine growth-stimulating activity in many EBV-immortalized cell lines (5) . Other molecules that might contribute to this activity include 3B6 interleukin 1 (IL-1), a structurally unique protein with IL-1 bioactivity (6), and soluble CD23, a B-cell activation antigen (7) .
Recently, we found that most of the autocrine growth factor activity (.70%) in serum-free supernatants of EBVimmortalized cells derives from a low molecular weight (<5000) factor (5) . There are many reports of incompletely identified low molecular weight growth factor(s) (8) (9) (10) (11) (12) (13) (14) (15) Determination of IL-6 Activity and LA Concentration. IL-6 bioactivity was determined in a standard proliferation assay using B9 cells as described (5) . LA was measured in a lactate dehydrogenase-based enzymatic assay (Sigma, diagnostic procedure no. 720-VV/826 VV).
Purification Procedures. Culture supernatant was filtered through an Amicon ultrafiltration unit with a YM-5 membrane, lyophilized, suspended in water containing 20%o ethanol (vol/vol), and then applied to a Bio-Gel P2 (Bio-Rad) column (3 x 100 cm) previously equilibrated in water containing 20% ethanol; elution was done at a flow rate of 10 ml/hr. Active fractions from the Bio-Gel P2 column were pooled, diluted in water to achieve a conductivity of 1.0, adjusted to pH 8.3 with ammonium hydroxide, then applied to a QAE Sephadex A-25 (Pharmacia) column (2.6 x 22 cm) previously equilibrated in water containing ammonium hydroxide (pH 8.3), and then eluted in water with the addition of 100 mM sodium chloride. Active fractions from the QAE Abbreviations: EBV, Epstein-Barr virus; LA, lactic acid; IL-6, interleukin 6; BSA, bovine serum albumin.
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column were pooled, concentrated by centrifugation in vacuo, adjusted to pH 6.5 by addition of hydrochloric acid, and then passed in sequence over a Bio-Sil A (Bio-Rad) column (1.5 x 13 cm) and a Bio-Beads SM-2 (Bio-Rad) column (1.5 x 13 cm) equilibrated in water. The unbound material that was biologically active was dialyzed extensively against water using dialysis tubing with a 100 molecular weight cutoff (Spectra/Por, Spectrum, Los Angeles) and then concentrated by centrifugation in vacuo. An aliquot (25 ,ul) ofthe concentrate was subjected to reversed-phase HPLC over a Hewlett-Packard C18 column (5 ,um, 100 x 2.1 mm) equilibrated in water and eluted in water at a flow rate of 0.15 ml/min. Active fractions from reverse-phase HPLC were pooled and an aliquot (25 Al) was subjected to hydrophylic interaction HPLC (18) over a Poly LC (Columbia, MD) poly(hydroxyethyl aspartamide) column (100 x 4.6 mm) equilibrated with a solution of 901% acetonitrile in water containing 15 mM triethylamine phosphate (pH 3.8) and eluted for 10 min with the equilibrating solution followed by a linear descending gradient of acetonitrile containing 15 mM triethylamine phosphate (pH 3.8) (from 90o to 30%o acetonitrile over 35 min) at a flow rate of 0.5 ml/min.
Mass Spectrometry. Purified fractions from cell culture supernatants that were known to be biologically active as well as corresponding fractions from control medium that were known to be biologically inactive were analyzed first by laser desorption ionization-Fourier transform mass spectrometry (19) . Subsequently, equal aliquots of active and inactive fractions were dried in vacuo and allowed to react 
RESULTS

Purification of a Low Molecular Weight Autocrine Growth
Factor. The starting material for this isolation was the culture supernatant of the EBV-induced lymphoblastoid cell line VDS-O incubated in serum-free medium at high density (0.5 x 106 cells per ml for 24 hr). Recovery of activity at each purification step was monitored by testing the proliferation of the indicator lymphoblastoid cell line VDS-O cultured in serum-free medium at low cell density (1.5 x 104 cells per ml) for 3 days. Under these low-density and serum-free conditions the indicator VDS-O cells stop proliferating and die, outcomes that can be prevented by supplementation of the culture medium with supernatant (or its active components) of lymphoblastoid cells cultured at high density (:2.5 x 1i0 cells per ml). Purification procedures are detailed in Fig. 1 . In a representative purification, we recovered -15% of the original biological activity. The purified material was analyzed by mass spectrometry (19) . Using laser desorption ionization-Fourier transform mass spectrometry, a negative ion series consistent with sodiated LA and oxalic acid [m/z (M + Na -H)J(M -H)] was prominent in the active fractions and absent in corresponding fractions derived from control medium. Subsequently, equal aliquots of active and inactive fractions were allowed to react with bis(trimethylsilyl)trifluoroacetamide and acetonitrile and analyzed on a HewlettPackard 5970 MSD with a 12 x 0.25 mm i.d. HP-1 column programed from 90°C to 250°C at 10°C/min while scanning from m/z 50 to 500. The total ion chromatogram indicated a major component with the retention time and mass spectrum of di(trimethylsilyl)lactic acid and a minor component identical to di(trimethylsilyl)oxalic acid in the active fraction that were not detectable in the procedural control. Thus, the purified material that was biologically active contained a N)
A. Bio-gel P-2 ;_ Gel Filtration and eluted at a flow rate of 10 ml/hr. (B) Active fractions from the gel filtration column were pooled, diluted in water to achieve a conductivity of 1.0 (300 ml), adjusted to pH 8.3, and applied to a QAE Sephadex A-25 column; the material was eluted with water containing 100 mM sodium chloride. (C and D) Active fractions from anion-exchange chromatography were concentrated to 10 ml, adjusted to pH 6.5, and passed over, in sequence, a Bio-Sil A column and Bio-Beads SM-2 column equilibrated in water. (E) The unbound material from the adsorption and gel permeation columns was dialyzed against water, concentrated to 2 ml, and applied (25 1l) to a C18 reverse-phase HPLC column; elution was done in water. (F) Active fractions from the C18 column were pooled and applied (25 ,ul) to a poly(hydroxyethyl aspartamide) column; elution was in 90%o acetonitrile containing 15 mM triethylamine phosphate over 10 min followed by a descending gradient of acetonitrile over 35 min.
major component identified as LA and a minor component identified as oxalic acid.
Identification of a Low Molecular Weight B-Cell Growth
Factor as LA. We tested whether LA and oxalic acid promote growth in EBV-immortalized cells incubated in serum-free medium at low cell densities. Synthetic LA enhanced the proliferation of the indicator VDS-O cells, but synthetic oxalic acid did not (Fig. 2) . Maximal stimulation was achieved at LA concentrations ranging between 2.4 and 4.8 mM. This was comparable in magnitude to that achieved by addition of serum-free supernatants of the VDS-O line that had been fractionated to contain predominantly molecules with a molecular weight <5000 and were diluted 1:2. The mean LA concentration in these undiluted VDS-O line supernatants was determined to be 6.7 x/. 1.1 mM (geometric mean x SEM). A lactate dehydrogenase-based enzymatic assay was used to measure LA in all cases.
When cultured for 3 days at low cell densities (2.0 x 104 cells per ml) in serum-free medium each of six EBV-induced lymphoblastoid cell lines showed low-level proliferation (Table 1). LA, added at 4.8 mM to these cultures, induced 4.0-to 12.5-fold increases in cell proliferation. This level of growth stimulation in the lymphoblastoid cells was comparable in magnitude to that induced by autologous culture supernatants produced in serum-free medium at high cell density (0.5 x 106 cells per ml for 24 hr), filtered through a 5000 molecular weight membrane, and diluted 1:2 ( Table 1) . The LA concentration in these undiluted supernatants was found to range between 7.1 and 14.8 mM. When crowded, lymphoblastoid cells stop proliferating and LA accumulates in the culture supernatant (7-15 mM) . When incubated at lower cell densities, lymphoblastoid cells proliferate and LA concentrations are lower. The mean LA concentration in supernatants of lymphoblastoid cells that proliferated from 5 x 104 to 23-32 x 104 cells per ml was found to be 3.6 mM (mean of three experiments). Thus, EBV-immortalized cell lines secrete LA in the culture supernatants and the-,evels achieved are stimulatory for EBV-immortalized cells.
Because IL-6 has been previously identified as an autocrine growth factor for EBV-immortalized B cells (5, 20) , we examined the combined growth-promotihg effects of LA and IL-6. When added to EBV-immortalized cells from three cell lines (VDS-O, FR, and MA) at the physiologic concentrations measured in the test serum-free culture supernatants of these lines, synthetic LA together with recombinant IL-6 reconstituted >95% of the autocrine growth-stimulatory activity of the autologous supernatants (Fig. 3) . Thus, LA and IL-6, together, account for most, if not all, of the autocrine growth factor activity in serum-free supernatants of EBVimmortalized B cells.
Functional Properties of LA. Growth stimulation by LA requires the presence of D-glucose and L-glutamine (Table 2) . A number of other monosaccharides, including fructose (Table 2) , D-mannose, and N-acetyl-D-glucosamine (not shown), failed to substitute for D-glucose over a wide range of concentrations (0.6-40 mg/ml). Fetal calf serum added in culture at levels .10% masked the growth-stimulatory effects of LA. After dialysis that removed LA (<0.02 mM residual LA), B-cell growth was still maximal (Table 2 ). This [3H]Thymidine (0.5 mCi per well) was added during the final 18 hr of culture. The results reflect the geometric mean radioactivity x/ .
SEM of five determinations.
Cell Biology: Pike et aL Exponentially growing EBV-immortalized cells from the VDS-O cell line were cultured for 3 days (5000 cells per 0.2-ml microwell in experiments 1, 2, and 4 and 1000 cells per 0.2-ml microwell in experiment 3) in RPMI 1640 medium containing BSA (1 mg/ml) and transferrin (2.5 Ag/ml) with or without LA (4. is likely due to other growth factors present in serum. Pyruvic acid as well as a number of other carboxylic acids (oxaloacetic acid, ketomalonic acid, 3-hydroxybutyric acid, 2-oxopentanoic acid, isobutyric acid, and 2-ketoglutaric acid) stimulated the proliferation of EBV-immortalized cells similarly to LA and, at optimal concentrations, masked stimulation by LA (Table 2) . At suboptimal concentrations LA and pyruvic acid had additive growth-promoting effects (not shown).
Aminooxyacetate, an inhibitor of several transaminases, including glutamate-oxaloacetate transaminase, has been shown to selectively inhibit gluconeogenesis from LA while affecting that from pyruvate much less (21, 22) . As shown (Fig. 4) , over a wide range of concentrations (0.015-1.0 mM), aminooxyacetate inhibited B-cell growth induced by LA by >80% and that from pyruvic acid by <35%. Thus, the autocrine growth-stimulatory effect of LA may require mitochondrial-cytosol transfers, analogous to those for hepatic gluconeogenesis from LA.
DISCUSSION
In this study, we have demonstrated that LA is the compound principally responsible for the survival and proliferation of EBV-immortalized B cells grown in serum-free conditions. When incubated at low cell densities in serum-free conditions, EBV-immortalized cells stop proliferating and die, outcomes that can be prevented by the addition of culture supernatants of EBV-immortalized cells grown at higher cell densities in the same medium. We have now found that this growth-promoting effect of culture supernatants is due, for the most part, to the LA they contain. This conclusion is supported by two sets of observations. (i) LA was found to be present in the serum-free culture supernatants of EBVimmortalized cells grown at high cell densities at concentrations ranging between 7 and i5 mM and copurified with the autocrine growth-stimulating activity over several steps of purification. ( (23) .
Until now, LA was generally considered a biologically inert metabolic product of glycolysis. In vivo, it is produced mainly by muscle cells and neoplastic tissues when oxygen becomes limiting (24, 25) . In vitro, it is produced by a various normal and neoplastic cells even when they are incubated aerobically (26) (27) (28) . It is known that utilization of LA is mainly limited to liver and kidney cells that are capable of gluconeogenesis from lactate (24) . Other cells that have been reported to utilize LA include the retina, which can recycle lactate (29), spermatocytes and spermatides, which can uti-lize lactate for RNA and protein synthesis (30), splenic T lymphocytes, which are induced to secrete T-cell growth factor (31) , and pancreatic islet cells, which are stimulated to secrete insulin (32) . However, LA has not been previously found to either be utilized by or promote growth in B lymphocytes.
There is considerable evidence for the existence of specialized transport systems for LA on the plasma membranes of various mammalian cells (33) , but the mechanism by which LA promotes growth in EBV-immortalized cells is incompletely understood. LA does not promote glucose transport (not shown) similar to what has been reported for certain growth factors (34) and oncogenes (35) . The observation that the glutamate-oxaloacetate transaminase inhibitor aminooxyacetate specifically inhibits growth induced by LA suggests that it may serve to augment cytosol-mitochondrial transfers and thereby increase ATP generation. Increased levels of ATP in the cell may trigger initiation of DNA replication, committing the cell to switch from quiescence to proliferation (36) .
In preliminary experiments, LA stimulated the proliferation of EBV-negative cell lines of various lineage, including human T-lymphotropic virus type I-transformed T lines, Burkitt lines, and monocytoid cell lines. Thus, growth stimulation by LA may not be limited to EBV-immortalized cells and may be common among immortalized/transformed cells.
We would speculate that LA may have a role in tumorigenesis. Malignant tumors are often poorly perfused as they increase in size. As a result, they become hypoxic and accumulate a number of metabolic products, particularly LA (25, 37) . If tumor cells can proliferate in vivo in response to LA, as shown here for EBV-immortalized cells in vitro, this would allow cell growth to continue in spite of oxygen and nutrient restrictions.
We report here that LA is a potent autostimulatory factor for human B cells immortalized by EBV. This property of LA provides a mean for understanding the molecular basis for autocrine growth stimulation.
